Anti-TNF

A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study
Sang-Cheol Bae, Jinseok Kim, Jung-Yoon Choe, Won Park, Sang-Heon Lee, Yong-Beom Park, Seung-Cheol Shim, Shin-Seok Lee, Yoon-Kyoung Sung, Chan-Bum Choi, So-Ra Lee, HanYu Park, Yongho Ahn

Annals of the Rheumatic Diseases Jan 2017, 76 (1) 65-71; DOI: 10.1136/annrheumdis-2015-207613
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja A Stamm, Jan W Schoones, Robert B M Landewé

Annals of the Rheumatic Diseases Jan 2023, 82 (1) 95-106; DOI: 10.1136/ard-2022-223365
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study
Won Park, Dae Hyun Yoo, Pedro Miranda, Marek Brzosko, Piotr Wiland, Sergio Gutierrez-Ureña, Helena Mikazane, Yeon-Ah Lee, Svitlana Smiyan, Mie-Jin Lim, Vladimir Kadinov, Carlos Abud-Mendoza, HoUng Kim, Sang Joon Lee, YunJu Bae, SuYeon Kim, Jürgen Braun

Annals of the Rheumatic Diseases Feb 2017, 76 (2) 346-354; DOI: 10.1136/annrheumdis-2015-208783
Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance
K L Winthrop, S A Novosad, J W Baddley, L Calabrese, T Chiller, P Polgreen, F Bartalesi, M Lipman, X Mariette, O Lortholary, M E Weinblatt, M Saag, J Smolen

Annals of the Rheumatic Diseases Dec 2015, 74 (12) 2107-2116; DOI: 10.1136/annrheumdis-2015-207841
OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy
Peter C Taylor, Mark C Genovese, Mike Greenwood, Meilien Ho, Evgeny Nasonov, Barry Oemar, Rumen Stoilov, Jiri Vencovsky, Michael Weinblatt

Annals of the Rheumatic Diseases Dec 2015, 74 (12) 2123-2129; DOI: 10.1136/annrheumdis-2014-205361
Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis
Noortje van Herwaarden, Chantal A M Bouman, Aatke van der Maas, Ronald F van Vollenhoven, Johannes W Bijlsma, Frank H J van den Hoogen, Alfons A den Broeder, Bart J F van den Bemt

Annals of the Rheumatic Diseases Dec 2015, 74 (12) 2260-2261; DOI: 10.1136/annrheumdis-2015-207814
Immunogenicity, drug trough levels and therapeutic response in patients with rheumatoid arthritis or ankylosing spondylitis after 24-week golimumab treatment
Der-Yuan Chen, Yi-Ming Chen, Wei-Ting Hung, Hsin-Hua Chen, Chia-Wei Hsieh, Yi-Hsing Chen, Wen-Nan Huang, Tsu-Yi Hsieh

Annals of the Rheumatic Diseases Dec 2015, 74 (12) 2261-2264; DOI: 10.1136/annrheumdis-2015-207978
Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al
Lea C Berkhout, Merel J l'Ami, Gerrit Jan Wolbink, Theo Rispens

Annals of the Rheumatic Diseases Nov 2021, 80 (11) e172; DOI: 10.1136/annrheumdis-2019-216557
Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study
Megan EB Clowse, Frauke Förger, Caroline Hwang, John Thorp, Radboud JEM Dolhain, Astrid van Tubergen, Laura Shaughnessy, Jeff Simpson, Marie Teil, Nathalie Toublanc, Maggie Wang, Thomas W Hale

Annals of the Rheumatic Diseases Nov 2017, 76 (11) 1890-1896; DOI: 10.1136/annrheumdis-2017-211384
Methotrexate and BAFF interaction prevents immunization against TNF inhibitors
Samuel Bitoun, Gaetane Nocturne, Bineta Ly, Roman Krzysiek, Pierre Roques, Alain Pruvost, Audrey Paoletti, Juliette Pascaud, Pierre Dönnes, Kimberly Florence, Aude Gleizes, Agnes Hincelin-Mery, Matthieu Allez, Salima Hacein-Bey-Abina, Fabienne Mackay, Marc Pallardy, Roger Le Grand, Xavier Mariette

Annals of the Rheumatic Diseases Oct 2018, 77 (10) 1463-1470; DOI: 10.1136/annrheumdis-2018-213403

Main menu

Anti-TNF

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Anti-TNF

Pages